These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20971927)

  • 21. Direct CD4 help provision following interaction of memory CD4 and CD8 T cells with distinct antigen-presenting dendritic cells.
    de Goër de Herve MG; Dembele B; Vallée M; Herr F; Cariou A; Taoufik Y
    J Immunol; 2010 Jul; 185(2):1028-36. PubMed ID: 20562265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
    Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
    Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons.
    de Bree GJ; Heidema J; van Leeuwen EM; van Bleek GM; Jonkers RE; Jansen HM; van Lier RA; Out TA
    J Infect Dis; 2005 May; 191(10):1710-8. PubMed ID: 15838799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness.
    Schwarze J; Cieslewicz G; Joetham A; Ikemura T; Hamelmann E; Gelfand EW
    J Immunol; 1999 Apr; 162(7):4207-11. PubMed ID: 10201948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity.
    Bont L; Versteegh J; Swelsen WT; Heijnen CJ; Kavelaars A; Brus F; Draaisma JM; Pekelharing-Berghuis M; van Diemen-Steenvoorde RA; Kimpen JL
    Pediatr Res; 2002 Sep; 52(3):363-7. PubMed ID: 12193668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.
    Rothoeft T; Fischer K; Zawatzki S; Schulz V; Schauer U; Körner Rettberg C
    Clin Exp Immunol; 2007 Nov; 150(2):263-73. PubMed ID: 17892510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining the breadth of the respiratory syncytial virus-specific T cell response.
    McDermott DS; Knudson CJ; Varga SM
    J Virol; 2014 Mar; 88(6):3135-43. PubMed ID: 24371055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection.
    Luangrath MA; Schmidt ME; Hartwig SM; Varga SM
    Immunohorizons; 2021 Feb; 5(2):59-69. PubMed ID: 33536235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses.
    Liu J; Cao S; Peppers G; Kim SH; Graham BS
    Eur J Immunol; 2014 Apr; 44(4):1058-68. PubMed ID: 24510524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.
    Liu J; Ruckwardt TJ; Chen M; Johnson TR; Graham BS
    J Virol; 2009 May; 83(10):4934-41. PubMed ID: 19264776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.
    Garg R; Shrivastava P; van Drunen Littel-van den Hurk S
    Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
    Li H; Callahan C; Citron M; Wen Z; Touch S; Monslow MA; Cox KS; DiStefano DJ; Vora KA; Bett A; Espeseth A
    PLoS One; 2017; 12(11):e0187642. PubMed ID: 29121080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.
    Chang J; Choi SY; Jin HT; Sung YC; Braciale TJ
    J Immunol; 2004 Jan; 172(1):503-8. PubMed ID: 14688360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection.
    Schmidt ME; Meyerholz DK; Varga SM
    Mucosal Immunol; 2020 May; 13(3):507-517. PubMed ID: 31844172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhinovirus has the unique ability to directly activate human T cells in vitro.
    Ilarraza R; Wu Y; Skappak CD; Ajamian F; Proud D; Adamko DJ
    J Allergy Clin Immunol; 2013 Feb; 131(2):395-404. PubMed ID: 23374267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Novel Respiratory Syncytial Virus CD4
    Schmidt ME; Varga SM
    Immunohorizons; 2019 Jan; 3(1):1-12. PubMed ID: 31356172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.
    de Waal L; Süzer Y; Wyatt LS; Sintnicolaas K; Sutter G; Moss B; Osterhaus AD; de Swart RL
    Viral Immunol; 2006; 19(4):669-78. PubMed ID: 17201662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.
    Schmidt ME; Knudson CJ; Hartwig SM; Pewe LL; Meyerholz DK; Langlois RA; Harty JT; Varga SM
    PLoS Pathog; 2018 Jan; 14(1):e1006810. PubMed ID: 29293660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infection.
    Wissinger EL; Stevens WW; Varga SM; Braciale TJ
    J Immunol; 2008 Mar; 180(5):2957-66. PubMed ID: 18292518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node.
    Lukens MV; Kruijsen D; Coenjaerts FE; Kimpen JL; van Bleek GM
    J Virol; 2009 Jul; 83(14):7235-43. PubMed ID: 19420085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.